Two thirds of the subjects ( n = 200 ) received a single titrated 0.5-2 ounce liquid dose of a novel polyphenol-based prebiotic ( Aliva ( TM ) ) diluted with 2 to eight ounces of oral rehydration solution ( ORS ) .